Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hirohide Asai

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Neuroscience Letters|May 9, 2007
Short half-lives of ataxia-associated aprataxin proteins in neuronal cellsMakito Hirano, Hirohide Asai, Takao Kiriyama, et al.
Parkinsonism & Related Disorders|November 3, 2005
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's diseaseHirohide Asai, Fukashi Udaka, Makito Hirano, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 3, 2015
miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic DysfunctionMaya E Woodbury, Robert W Freilich, Christopher J Cheng, et al.
Nature Neuroscience|October 6, 2015
Depletion of microglia and inhibition of exosome synthesis halt tau propagationHirohide Asai, Seiko Ikezu, Satoshi Tsunoda, et al.
Neuroscience Letters|October 4, 2005
Cytoprotective effect of novel histone deacetylase inhibitors against polyglutamine toxicityShingo Kariya, Makito Hirano, Shinichi Uesato, et al.
Human Molecular Genetics|June 30, 2009
Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxinHirohide Asai, Makito Hirano, Keiji Shimada, et al.
Nature Communications|January 13, 2016
Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's diseaseQingde Zhou, Allen Yen, Grzegorz Rymarczyk, et al.
Neurobiology of Disease|January 14, 2020
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease modelTomohiro Imamura, Yuki T Yanagihara, Yasumasa Ohyagi, et al.
Journal of the Neurological Sciences|February 17, 2007
Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALSHirohide Asai, Makito Hirano, Fukashi Udaka, et al.
Annals of Neurology|February 23, 2007
DNA single-strand break repair is impaired in aprataxin-related ataxiaMakito Hirano, Aya Yamamoto, Toshio Mori, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Neuroscience Letters|May 9, 2007
Short half-lives of ataxia-associated aprataxin proteins in neuronal cellsMakito Hirano, Hirohide Asai, Takao Kiriyama, et al.
Parkinsonism & Related Disorders|November 3, 2005
Increased gastric motility during 5-HT4 agonist therapy reduces response fluctuations in Parkinson's diseaseHirohide Asai, Fukashi Udaka, Makito Hirano, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|July 3, 2015
miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic DysfunctionMaya E Woodbury, Robert W Freilich, Christopher J Cheng, et al.
Nature Neuroscience|October 6, 2015
Depletion of microglia and inhibition of exosome synthesis halt tau propagationHirohide Asai, Seiko Ikezu, Satoshi Tsunoda, et al.
Neuroscience Letters|October 4, 2005
Cytoprotective effect of novel histone deacetylase inhibitors against polyglutamine toxicityShingo Kariya, Makito Hirano, Shinichi Uesato, et al.
Human Molecular Genetics|June 30, 2009
Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxinHirohide Asai, Makito Hirano, Keiji Shimada, et al.
Nature Communications|January 13, 2016
Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's diseaseQingde Zhou, Allen Yen, Grzegorz Rymarczyk, et al.
Neurobiology of Disease|January 14, 2020
Insulin deficiency promotes formation of toxic amyloid-β42 conformer co-aggregating with hyper-phosphorylated tau oligomer in an Alzheimer's disease modelTomohiro Imamura, Yuki T Yanagihara, Yasumasa Ohyagi, et al.
Journal of the Neurological Sciences|February 17, 2007
Sympathetic disturbances increase risk of sudden cardiac arrest in sporadic ALSHirohide Asai, Makito Hirano, Fukashi Udaka, et al.
Annals of Neurology|February 23, 2007
DNA single-strand break repair is impaired in aprataxin-related ataxiaMakito Hirano, Aya Yamamoto, Toshio Mori, et al.
Pageof 3